Clinical Trials Directory

Trials / Sponsors / OBI Pharma, Inc

OBI Pharma, Inc

Industry · 9 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Study Evaluating OBI-902 in Participants With Advanced Solid Tumors
Advanced Solid Tumor
Phase 1 / Phase 22025-08-04
Active Not RecruitingA Phase 1/2 Study of OBI-992 in Subjects With Advanced Solid Tumors
Advanced Solid Tumor
Phase 1 / Phase 22024-06-12
RecruitingTo Evaluate OBI-833/OBI-821 in Combination With First-Line Erlotinib in Patients With EGFR-Mutated, Globo H-Po
Non-small Cell Lung Cancer
Phase 22022-07-27
TerminatedPhase 1/2 Study of OBI-999 in Patients With Advanced Solid Tumors
Locally Advanced Solid Tumor
Phase 1 / Phase 22019-11-25
Active Not RecruitingStudy of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNB
Triple Negative Breast Cancer
Phase 32018-12-05
TerminatedA Phase I/II Study of OBI-3424 in Subjects with Advanced Solid Tumors
Solid Tumor, Pancreatic Adenocarcinoma
Phase 1 / Phase 22018-07-02
TerminatedThis Study is to Evaluate Safe and Effective Treatment Dose of OBI-888 in Patients With Locally Advanced or Me
Metastatic Solid Tumors, Locally Advanced Solid Tumors
Phase 1 / Phase 22018-05-07
CompletedTrial of Active Immunotherapy With OBI-833 (Globo H-CRM197) in Advanced/Metastatic Gastric, Lung, Colorectal o
Metastatic Gastric Cancer, Metastatic Breast Cancer, Metastatic Colorectal Cancer
Phase 12015-12-22
CompletedTrial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects
Metastatic Breast Cancer
Phase 22011-12-01